Prashant Tailor, MD Mayo Clinic, Rochester, MN For the debate on Current Complement Inhibition Therapy for Geographic Atrophy is Acceptable, we had Dr. Chakravarthy (Pro) and Dr. Spaide (Con). Dr.…
Prashant Tailor, MD Mayo Clinic, Rochester, MN In his talk titled “What’s Next in Wet AMD,” Dr. Peter Kaiser delved into the latest advancements and future directions in the treatment…
David Xu, MD Wills Eye Hospital, Philadelphia, PA The highly anticipated two-year results of the GATHER2 trial of avacincaptad pegol for geographic atrophy was presented by Dr. Arshad Khanani at…
Jovi C.Y. Wong, MD, MSc, DPhil University of Toronto The AAO 2023 Retina Subspecialty Friday afternoon session Late Breaking Developments (Part 1) continued with the exciting release of the ARCHER…
Jovi C.Y. Wong, MD, MSc, DPhil University of Toronto At AAO 2023 Retina Subspecialty Day 1, the most anticipated session of the afternoon was the Late Breaking Developments (Part 1),…
Giulia Corradetti, MD Doheny Eye Institute Pasadena, CA On the second day of the Retina Society Meeting in New York City, Dr. Allen Ho from Philadelphia, PA, presented the late-breaking…
Warren Pan, MD, MPhil, PhD University of Michigan The following sessions on Saturday morning were moderated by Dean Eliott, MD and Maria Berrocal, MD. First, Dr. Leo Kim, MD, PhD…
H. Russell Day, MD Vanderbilt Eye Institute, Nashville, TN Sunir Garg, MD from the Wills Eye Hospital presented his work on pooled safety data from the aflibercept 8 mg trials.…